Skip to main content

Advertisement

SpringerLink
Log in

The Initial Management and Endoscopic Outcomes of Dyspepsia in a Low-Risk Patient Population

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background and Aims

Dyspepsia is frequently encountered by primary care providers (PCP) and gastroenterologists (GI). While esophagogastroduodenoscopy (EGD) may be useful, current guidelines suggest a proton pump inhibitor (PPI) trial and H. pylori (HP) test-and-treat before EGD for low-risk patients. This study aimed to evaluate pre-EGD management and endoscopic outcomes in this population.

Methods

This was a retrospective cohort study of low-risk dyspepsia patients (age ≤55, no alarm features) undergoing EGD at an ambulatory endoscopy center from January 2011 to March 2012. Adherences to initial management guidelines (PPI trial and HP test-and-treat strategy before EGD) were compared between PCP and GI. Endoscopic and pathologic outcomes were assessed for all patients. Statistical analyses were performed using Chi-squared test (categorical variables) and Student’s t test (continuous variables). This study received IRB approval (2011P001715).

Results

A total of 309 low-risk patients underwent EGD for dyspepsia. Only 202 (65.4 %) had HP testing, and 220 (71.2 %) were trialed on any dose/length PPI pre-EGD, with no differences between PCP and GI. PPI exposure was similar between groups for all dose/duration except for trials ≥8 weeks of any dose (46.9 % GI vs 34.3 % PCP, p = 0.03) and high dose (32 % GI vs 18.7 % PCP, p = 0.01). Overall, only 178 (57.6 %) patients had both HP testing and any PPI exposure pre-EGD (56.6 % GI vs 59 % PCP, p = 0.73). Significant pathology was rare, with gastritis (46.6 %) and HP (17.2 %) being most common. No malignancy was found.

Conclusions

A significant proportion of low-risk dyspepsia patients did not receive any PPI trial or HP testing before EGD. Within this population, significant finding on EGD was rare, supporting the current noninvasive initial management guidelines for dyspepsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Piessevaux H, De Winter B, Louis E, et al. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil. 2009;21:378–388.

    Article  CAS  PubMed  Google Scholar 

  2. Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol. 2004;99:2210–2216.

    Article  PubMed  Google Scholar 

  3. Russo M, Wei J, Thiny M, et al. Digestive and liver diseases statistics, 2004. Gastroenterology. 2004;126:1448–1453.

    Article  PubMed  Google Scholar 

  4. Tack J, Talley N, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479.

    Article  PubMed  Google Scholar 

  5. Fransen GAJ, Janssen MJR, Muris JWM, et al. Meta-analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy. Aliment Pharmacol Ther. 2004;20:1045–1052.

    Article  CAS  PubMed  Google Scholar 

  6. Wai C, Yeoh K, Ho K, et al. Diagnostic yield of upper endoscopy in Asian patients presenting with dyspepsia. Gastrointest Endosc. 2002;56:548–551.

    Article  PubMed  Google Scholar 

  7. Vakil N, Moayyedi P, Fennerty M, et al. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006;131:390–401.

    Article  PubMed  Google Scholar 

  8. Ikenberry S, Harrison M, Lichtenstein D, the ASGE Standards of Practice Committee. The role of endoscopy in dyspepsia. Gastrointest Endosc. 2007;66:1071–1075.

    Article  PubMed  Google Scholar 

  9. Talley NJ. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology. 2005;129:1753–1755.

    Article  PubMed  Google Scholar 

  10. Talley NJ, Vakil N, Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005;100:2324–2337.

    Article  PubMed  Google Scholar 

  11. Salo M, Collin P, Kyronpalo S, et al. Age, symptoms and upper gastrointestinal malignancy in primary care endoscopy. Scand J Gastroenterol. 2008;43:122–127.

    Article  PubMed  Google Scholar 

  12. Bai Y, Li ZS, Zou DW, et al. Alarm features and age for predicting upper gastrointestinal malignancy in Chinese patients with dyspepsia with high background prevalence of Helicobacter pylori infection and upper gastrointestinal malignancy: an endoscopic database review of 102,665 patients from 1996 to 2006. Gut. 2010;59:722–728.

    Article  PubMed  Google Scholar 

  13. Bowrey DJ, Griffin SM, Wayman J, et al. Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked. Surg Endosc. 2006;20:1725–1728.

    Article  CAS  PubMed  Google Scholar 

  14. Choi J, Kim SG, Im JP, et al. Long-term clinical outcomes of endoscopic resection for early gastric cancer. Surg Endosc. 2015;29:1223–1230.

    Article  PubMed  Google Scholar 

  15. Kavic SM, Basson MD. Complications of endoscopy. Am J Surg. 2001;181:319–332.

    Article  CAS  PubMed  Google Scholar 

  16. Lacy BE, Weiser KT, Kennedy AT, et al. Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther. 2013;38:170–177.

    Article  CAS  PubMed  Google Scholar 

  17. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975–2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

  18. Mahadeva S, Goh K-L. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol. 2006;12:2661–2666.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Charles RJ, Cooper GS, Wong RC, et al. Effectiveness of open-access endoscopy in routine primary-care practice. Gastrointest Endosc. 2003;57:183–186.

    Article  PubMed  Google Scholar 

  20. Wang WH, Huang JQ, Zheng GF, et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol. 2007;5:178–185.

    Article  CAS  PubMed  Google Scholar 

  21. Hirota WK, Zuckerman MJ, Adler DG, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63:570–580.

    Article  PubMed  Google Scholar 

  22. Miwa H, Ghoshal UC, Gonlachanvit S, et al. Asian consensus report on functional dyspepsia. J Neurogastroenterol Motil. 2012;18:150–168.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author contributions

J.P.F. and W.W.C. contributed to study conception and design. J.P.F., A.M.T., and W.W.C. contributed to data acquisition, analysis and interpretation, manuscript drafting, and critical revisions for intellectual content.

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA, 02115, USA

    Jeffrey P. Fiorenza & Walter W. Chan

  2. Harvard Medical School, Boston, MA, USA

    Jeffrey P. Fiorenza & Walter W. Chan

  3. Harvard School of Public Health, Boston, MA, USA

    Alex M. Tinianow

Authors
  1. Jeffrey P. Fiorenza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alex M. Tinianow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Walter W. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Walter W. Chan.

Ethics declarations

Conflict of interest

The authors do not report any conflict of interests and have no financial disclosures relevant to the subjects of the manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fiorenza, J.P., Tinianow, A.M. & Chan, W.W. The Initial Management and Endoscopic Outcomes of Dyspepsia in a Low-Risk Patient Population. Dig Dis Sci 61, 2942–2948 (2016). https://doi.org/10.1007/s10620-016-4051-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-016-4051-3

Keywords

Search

Navigation